Perbandingan tingkat keberhasilan implan antara osteogenesis distraksi dengan autogenous bone graft Ratio of successful rate of dental implan between distraction osteogenesis with autogenous bone graft

Abstract

Endosseous dental implants are the treatment of choice for restoring function and reconstructing most edentulousareas of the maxilla and mandible. One of the most common problems in oral implantology is insufficient bone heightbetween the alveolar ridge and the mandible canal, as a result of mandibular atrophy from edentulism. Generally,alveolar bone defects can be reconstructed by either distraction osteogenesis (DO)or autogenous bone grafting(ABG). This paper discussed implant successful rate in DO versus ABG. DO shows a higher successful rate of implantthan ABG with the result more esthetic, lower rate of infection and bone resorption, no pain at donor area, andrelatively uncomplicated.

Biocompatibility of crab shell-derived graft sterilized by ultraviolet light towards human gingival fibroblast cell culture

“…The structure of HA has a similar structure with human bones which makes HA have the potential and innovation as a manufacture of synthetic bones (bone graft). In dentistry, bone graft is used to increase the alveolar bone volume, remodeling the jawbone, and reshaping the alveolar crest [5,6].…”

A comparative study of platelet rich fibrin and bone graft in intrabony defect treatment: A systematic review

“…Lastly, alloplasts are synthetically developed bone replacement grafts fabricated from various laboratory materials including hydroxyapatite and betatricalcium phosphate. 2, 3 In recent years, researchers have focused on biological mediators which have the ability to enhance wound healing and improve clinical benefits of bone replacement grafts.6 Polypeptide growth factors are biological mediators which regulate cell proliferation, chemotaxis and differentiation and induce periodontal regeneration. To deliver high concentrations of polypeptide growth factors to periodontal surgical wounds, use of autologous platelet concentrates serve as a safe and appropriate approach.…”